Literature DB >> 19892860

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

Wendy C Moore1, Deborah A Meyers, Sally E Wenzel, W Gerald Teague, Huashi Li, Xingnan Li, Ralph D'Agostino, Mario Castro, Douglas Curran-Everett, Anne M Fitzpatrick, Benjamin Gaston, Nizar N Jarjour, Ronald Sorkness, William J Calhoun, Kian Fan Chung, Suzy A A Comhair, Raed A Dweik, Elliot Israel, Stephen P Peters, William W Busse, Serpil C Erzurum, Eugene R Bleecker.   

Abstract

RATIONALE: The Severe Asthma Research Program cohort includes subjects with persistent asthma who have undergone detailed phenotypic characterization. Previous univariate methods compared features of mild, moderate, and severe asthma.
OBJECTIVES: To identify novel asthma phenotypes using an unsupervised hierarchical cluster analysis.
METHODS: Reduction of the initial 628 variables to 34 core variables was achieved by elimination of redundant data and transformation of categorical variables into ranked ordinal composite variables. Cluster analysis was performed on 726 subjects.
MEASUREMENTS AND MAIN RESULTS: Five groups were identified. Subjects in Cluster 1 (n = 110) have early onset atopic asthma with normal lung function treated with two or fewer controller medications (82%) and minimal health care utilization. Cluster 2 (n = 321) consists of subjects with early-onset atopic asthma and preserved lung function but increased medication requirements (29% on three or more medications) and health care utilization. Cluster 3 (n = 59) is a unique group of mostly older obese women with late-onset nonatopic asthma, moderate reductions in FEV(1), and frequent oral corticosteroid use to manage exacerbations. Subjects in Clusters 4 (n = 120) and 5 (n = 116) have severe airflow obstruction with bronchodilator responsiveness but differ in to their ability to attain normal lung function, age of asthma onset, atopic status, and use of oral corticosteroids.
CONCLUSIONS: Five distinct clinical phenotypes of asthma have been identified using unsupervised hierarchical cluster analysis. All clusters contain subjects who meet the American Thoracic Society definition of severe asthma, which supports clinical heterogeneity in asthma and the need for new approaches for the classification of disease severity in asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892860      PMCID: PMC2822971          DOI: 10.1164/rccm.200906-0896OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  42 in total

Review 1.  Asthma phenotypes.

Authors:  James Kiley; Robert Smith; Patricia Noel
Journal:  Curr Opin Pulm Med       Date:  2007-01       Impact factor: 3.155

Review 2.  Asthma: defining of the persistent adult phenotypes.

Authors:  Sally E Wenzel
Journal:  Lancet       Date:  2006-08-26       Impact factor: 79.321

3.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Authors:  Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

4.  IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression.

Authors:  Sally E Wenzel; Silvana Balzar; Elizabeth Ampleford; Gregory A Hawkins; William W Busse; William J Calhoun; Mario Castro; K Fan Chung; Serpil Erzurum; Benjamin Gaston; Elliot Israel; W Gerald Teague; Douglas Curran-Everett; Deborah A Meyers; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2006-12-14       Impact factor: 21.405

5.  Severity assessment in asthma: An evolving concept.

Authors:  Mary K Miller; Charles Johnson; Dave P Miller; Yamo Deniz; Eugene R Bleecker; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2005-10-03       Impact factor: 10.793

6.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.

Authors:  Suzy A A Comhair; Kristin S Ricci; Mercedes Arroliga; Abigail R Lara; Raed A Dweik; Wei Song; Stanley L Hazen; Eugene R Bleecker; William W Busse; Kian Fan Chung; Benjamin Gaston; Annette Hastie; Mark Hew; Nizar Jarjour; Wendy Moore; Stephen Peters; W Gerald Teague; Sally E Wenzel; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

7.  Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide.

Authors:  Anne M Fitzpatrick; Benjamin M Gaston; Serpil C Erzurum; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2006-10-10       Impact factor: 10.793

8.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

9.  Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies.

Authors:  David A Beuther; E Rand Sutherland
Journal:  Am J Respir Crit Care Med       Date:  2007-01-18       Impact factor: 21.405

10.  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial.

Authors:  Dominick E Shaw; Mike A Berry; Mike Thomas; Ruth H Green; Chris E Brightling; Andrew J Wardlaw; Ian D Pavord
Journal:  Am J Respir Crit Care Med       Date:  2007-05-11       Impact factor: 21.405

View more
  588 in total

Review 1.  Lung imaging in asthmatic patients: the picture is clearer.

Authors:  Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel
Journal:  J Allergy Clin Immunol       Date:  2011-06-02       Impact factor: 10.793

2.  Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma.

Authors:  Mats W Johansson; Shih-Tsung Han; Kristin A Gunderson; William W Busse; Nizar N Jarjour; Deane F Mosher
Journal:  Am J Respir Crit Care Med       Date:  2012-01-06       Impact factor: 21.405

3.  Methylated Genes in Sputum Among Older Smokers With Asthma.

Authors:  Akshay Sood; Hans Petersen; Christopher M Blanchette; Paula Meek; Maria A Picchi; Steven A Belinsky; Yohannes Tesfaigzi
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

4.  Resequencing candidate genes implicates rare variants in asthma susceptibility.

Authors:  Dara G Torgerson; Daniel Capurso; Rasika A Mathias; Penelope E Graves; Ryan D Hernandez; Terri H Beaty; Eugene R Bleecker; Benjamin A Raby; Deborah A Meyers; Kathleen C Barnes; Scott T Weiss; Fernando D Martinez; Dan L Nicolae; Carole Ober
Journal:  Am J Hum Genet       Date:  2012-02-10       Impact factor: 11.025

5.  ALX receptor ligands define a biochemical endotype for severe asthma.

Authors:  Isabell Ricklefs; Ioanna Barkas; Melody G Duvall; Manuela Cernadas; Nicole L Grossman; Elliot Israel; Eugene R Bleecker; Mario Castro; Serpil C Erzurum; John V Fahy; Benjamin M Gaston; Loren C Denlinger; David T Mauger; Sally E Wenzel; Suzy A Comhair; Andrea M Coverstone; Merritt L Fajt; Annette T Hastie; Mats W Johansson; Michael C Peters; Brenda R Phillips; Bruce D Levy
Journal:  JCI Insight       Date:  2017-07-20

6.  Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.

Authors:  Kathryn Blake; James D Cury; Jobayer Hossain; Kelan Tantisira; Jianwei Wang; Edward Mougey; John Lima
Journal:  Pulm Pharmacol Ther       Date:  2013-02-04       Impact factor: 3.410

7.  Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.

Authors:  W Gerald Teague; Brenda R Phillips; John V Fahy; Sally E Wenzel; Anne M Fitzpatrick; Wendy C Moore; Annette T Hastie; Eugene R Bleecker; Deborah A Meyers; Stephen P Peters; Mario Castro; Andrea M Coverstone; Leonard B Bacharier; Ngoc P Ly; Michael C Peters; Loren C Denlinger; Sima Ramratnam; Ronald L Sorkness; Benjamin M Gaston; Serpil C Erzurum; Suzy A A Comhair; Ross E Myers; Joe Zein; Mark D DeBoer; Anne-Marie Irani; Elliot Israel; Bruce Levy; Juan Carlos Cardet; Wanda Phipatanakul; Jonathan M Gaffin; Fernando Holguin; Merritt L Fajt; Shean J Aujla; David T Mauger; Nizar N Jarjour
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-31

8.  Effects of Coexisting Asthma and Obstructive Sleep Apnea on Sleep Architecture, Oxygen Saturation, and Systemic Inflammation in Women.

Authors:  Fredrik Sundbom; Christer Janson; Andrei Malinovschi; Eva Lindberg
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

Review 9.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

10.  Differentiating asthma phenotypes in young adults through polyclonal cytokine profiles.

Authors:  Edward Zoratti; Suzanne Havstad; Ganesa Wegienka; Charlotte Nicholas; Kevin R Bobbitt; Kimberley J Woodcroft; Dennis R Ownby; Christine Cole Johnson
Journal:  Ann Allergy Asthma Immunol       Date:  2014-05-05       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.